Renal toxicities associated with pembrolizumab

OBJECTIVE: Expanded clinical experience with patients treated by pembrolizumab has accumulated. However, renal toxicities associated with this anti-programmed cell death 1 agent are poorly described because kidney histology is rarely sought. As a nephrology referral centre, we aimed to describe the...

Descripción completa

Detalles Bibliográficos
Autores principales: Izzedine, Hassan, Mathian, Alexis, Champiat, Stephane, Picard, Cécile, Mateus, Christine, Routier, Emilie, Varga, Andrea, Malka, David, Leary, Alexandra, Michels, Judith, Michot, Jean-Marie, Marabelle, Aurélien, Lambotte, Olivier, Amoura, Zahir, Soria, Jean-Charles, Kaaki, Sihem, Quellard, Nathalie, Goujon, Jean-Michel, Brocheriou, Isabelle
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Oxford University Press 2018
Materias:
Drug-Induced Nephropathies
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC6366307/
https://www.ncbi.nlm.nih.gov/pubmed/30746132
http://dx.doi.org/10.1093/ckj/sfy100

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC6366307/
https://www.ncbi.nlm.nih.gov/pubmed/30746132
http://dx.doi.org/10.1093/ckj/sfy100

Ejemplares similares